M1 CRPC: First and Second Line Treatment Options [Video]

M1 CRPC: First and Second Line Treatment Options: Elisabeth Heath, MD, FACP

CME AVAILABLE: https://auau.auanet.org/node/40997

ACKNOWLEDGEMENTS
This educational activity is supported by independent educational grants from:
Astellas
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Pfizer, Inc.